Description
Desmethyl VS5584 Is an intermediate in the synthesis of purine analogs and potential tyrosine kinase inhibitor. This analog is a highly selective PI3K/mTOR kinase inhibitor.
Product Unit Size | Cost | Quantity | Stock |
---|
Desmethyl VS5584 Is an intermediate in the synthesis of purine analogs and potential tyrosine kinase inhibitor. This analog is a highly selective PI3K/mTOR kinase inhibitor.
Cas No. | 1246535-95-4 |
---|---|
Purity | ≥98% |
Formula | C16H20N8O |
Formula Wt. | 340.39 |
IUPAC Name | 5-[9-Isopropyl-2-(4-morpholinyl)-9H-purin-6-yl]-2-pyrimidinamine |
Synonym | Desmethyl-VS-5584, Desmethyl VS5584, Desmethyl VS 5584, VS-5584 Analog |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Zhou C, Li X, He A, et al. Development of a UPLC-MS/MS method for the quantification of VS-5584 and its application in pharmacokinetic studies in rats. J Anal Methods Chem. 2020 Dec 16;2020:8811522. PMID: 33381351.
Chen Y, Tsai H, Tsai Y, et al. VS-5584, a PI3K/mTOR dual inhibitor, exerts antitumor effects on neuroblastomas in vitro and in vivo. J Pediatr Surg. 2021 Aug;56(8):1441-1448. PMID: 33189297.
Xu M, Xu L, Wang Y, et al. BRD4 inhibition sensitizes renal cell carcinoma cells to the PI3K/mTOR dual inhibitor VS-5584. Aging (Albany NY). 2020 Oct 13;12(19):19147-19158. PMID: 33051401.
Phenylpyrazoleanilide; IL-17 production inhibit...
Aminoglycoside; protein translation inhibitor.<...
Fermentation impurity
MDM2-p53 inhibitor
Endogenous cardiomodulatory peptide; NPR-B agon...
Caffeic acid derivative.
Phenylpropanoid found in Castilleja, Verbena, V...
Mycotoxin produced by Aspergillus; actin polyme...
5-HT1A agonist, 5-HT2A antagonist.
AChE inhibitor.
EGFR and PDGFR inhibitor
USP1 inhibitor
Plasminogen inhibitor.
Micronuclei formation inducer, antimitotic, oxi...
SGLT2 inhibitor
Geldanamycin derivative; HSP90 inhibitor.
Src and Abl inhibitor.
Non-depolarizing NMJ blocker; nAChR antagonist....
Iron chelator.
Fluoroquinolone; bacterial DNA gyrase inhibitor...